1. Jahangiri S, Abtahi Froushani SM, Delirezh N. Combination immunotherapy with extract of heated 4T1 and naloxone in mouse model of breast cancer. Turk J Med Sci 2016;46:518-23. doi: 10.3906/sag-1410-61. 2. Mohammadi A, Abtahi Froushani SM, DelireZh N, Ownagh A. Alum and metoclopramide synergistically enhance cellular and humoral immunity after immunization with heat-killed Salmonella typhimurium vaccine. Int Immunopharmacol 2021; 101:108185. doi: 10.1016/j.intimp.2021.108185. 3. Arias-Carrión O, Stamelou M, Murillo-Rodríguez E, Menéndez-González M, Pöppel E. Dopaminergic reward system: a short integrative review. Int Arch Med 2010; 3:24. doi: 10.1186/1755-7682-3-24. 4. Franco R, Reyes-Resina I, Navarro G. Dopamine in Health and Disease: Much More Than a Neurotransmitter. Biomedicines 2021;9:109. doi: 10.3390/biomedicines9020109. 5. Arreola R, Alvarez-Herrera S, Pérez-Sánchez G, Becerril-Villanueva E, Cruz-Fuentes C, Flores-Gutierrez EO, et al. Immunomodulatory Effects Mediated by Dopamine. J Immunol Res 2016; 2016:3160486. doi: 10.1155/2016/3160486. 6. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete PF, Gonzalez-Figueroa P, et al. T(FH)-derived dopamine accelerates productive synapses in germinal centres. Nature 2017;547:318-23. doi: 10.1038/nature23013. 7. Nourmohammadi K, Babaei-Balderlou F, Abtahi-Foroushani SM. Dopamine D2 Receptor Antagonist Alters the Testosterone Release and Kisspeptin/GPR54 Signaling in Food-Restricted Rats. Iran J Sci Technol Trans Sci 2021;45:1879-86. doi:10.1007/s40995-021-01196-z. 8. Ehrchen JM, Roth J, Barczyk-Kahlert K. More Than Suppression: Glucocorticoid Action on Monocytes and Macrophages. Front Immunol 2019; 10:2028. doi: 10.3389/fimmu.2019.02028. 9. Esmaili Gourvarchin Galeh H, Meysam Abtahi Froushani S, Afzale Ahangaran N, Hadai SN. Effects of Educated Monocytes with Xenogeneic Mesenchymal Stem Cell-Derived Conditioned Medium in a Mouse Model of Chronic Asthma. Immunol Invest 2018;47:504-20. doi: 10.1080/08820139.2018. 10. Torres KC, Antonelli LR, Souza AL, Teixeira MM, Dutra WO, Gollob KJ. Norepinephrine, dopamine and dexamethasone modulate discrete leukocyte subpopulations and cytokine profiles from human PBMC. J Neuroimmunol 2005;166:144-57. doi: 10.1016/j.jneuroim.2005.06.006. 11. McKenna F, McLaughlin PJ, Lewis BJ, Sibbring GC, Cummerson JA, Bowen-Jones D, et al. Dopamine receptor expression on human T- and B-lymphocytes, monocytes, neutrophils, eosinophils and NK cells: a flow cytometric study. J Neuroimmunol 2002;132:34-40. doi: 10.1016/s0165-5728(02)00280-1. 12. Scriba A, Luciano L, Steiniger B. High-yield purification of rat monocytes by combined density gradient and immunomagnetic separation. J Immunol Methods 1996;189:203-16. doi: 10.1016/0022-1759(95)00248-0. 13. Abtahi Froushani SM, Abbasi A. Conditioned Medium of Mesenchymal Stem Cells Pulsed with Theobromine Can Instruct Anti-Inflammatory Neutrophils. Zahedan J Res Med Sci 2020;22:e86967. doi:10.5812/zjrms.86967. 14. Shushtari N, Abtahi Froushani SM. Caffeine Augments the Instruction of Anti-Inflammatory Macrophages by The Conditioned Medium of Mesenchymal Stem Cells. Cell J 2017;19:415-24. doi: 10.22074/cellj.2017.4364. 15. Fijalkowski K, Czernomysy-Furowicz D, Irwin JA, Nawrotek P, Pobucewicz A. Secretory virulence factors produced by Staphylococcus aureus isolates obtained from mastitic bovine milk--effect on bovine polymorphonuclear neutrophils. Res Vet Sci 2012;93:82-7. doi: 10.1016/j.rvsc.2011.08.017. 16. Pacheco R, Riquelme E, Kalergis AM. Emerging evidence for the role of neurotransmitters in the modulation of T cell responses to cognate ligands. Cent Nerv Syst Agents Med Chem 2010;10:65-83. doi: 10.2174/187152410790780154. 17. Pacheco R. Targeting dopamine receptor D3 signalling in inflammation. Oncotarget 2017;8:7224-5. doi: 10.18632/oncotarget.14601. 18. Contreras F, Prado C, González H, Franz D, Osorio-Barrios F, Osorio F, et al. Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity. J Immunol 2016;196:4143-9. doi: 10.4049/jimmunol.1502420. 19. Cosentino M, Bombelli R, Ferrari M, Marino F, Rasini E, Maestroni GJ, et al. HPLC-ED measurement of endogenous catecholamines in human immune cells and hematopoietic cell lines. Life Sci 2000;68:283-95. doi: 10.1016/s0024-3205(00)00937-1. 20. Arreola R, Alvarez-Herrera S, Pérez-Sánchez G, Becerril-Villanueva E, Cruz-Fuentes C, Flores-Gutierrez EO, et al. Immunomodulatory Effects Mediated by Dopamine. J Immunol Res 2016; 2016:3160486. doi: 10.1155/2016/3160486. 21. Haskó G, Szabó C, Németh ZH, Deitch EA. Dopamine suppresses IL-12 p40 production by lipopolysaccharide-stimulated macrophages via a β-adrenoceptor-mediated mechanism. J Neuroimmunol 2002;122:34-9. doi: 10.1016/s0165-5728(01)00459-3. 22. Nolan RA, Muir R, Runner K, Haddad EK, Gaskill PJ. Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders. J Neuroimmune Pharmacol 2019;14:134-56. doi: 10.1007/s11481-018-9825-2. 23. Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, et al. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 2012;135:3453-68. doi: 10.1093/brain/aws256. 24. Beck G, Brinkkoetter P, Hanusch C, Schulte J, van Ackern K, van der Woude FJ, et al. Clinical review: immunomodulatory effects of dopamine in general inflammation. Crit Care 2004;8:485-91. doi: 10.1186/cc2879. 25. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 2006;25:6680-4. doi: 10.1038/sj.onc.1209954. 26. Albensi BC. What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion? Front Cell Dev Biol 2019; 7:154. doi: 10.3389/fcell.2019.00154. 27. Gaskill PJ, Carvallo L, Eugenin EA, Berman JW. Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse. J Neuroinflammation 2012; 9:203. doi: 10.1186/1742-2094-9-203. 28. Cutolo M, Campitiello R, Gotelli E, Soldano S. The Role of M1/M2 Macrophage Polarization in Rheumatoid Arthritis Synovitis. Front Immunol 2022; 13:867260. doi: 10.3389/fimmu.2024.1394108. 29. Bart VMT, Pickering RJ, Taylor PR, Ipseiz N. Macrophage reprogramming for therapy. Immunology 2021;163:128-44. doi: 10.1111/imm.13300.
|